Related Experiment Video
Updated: Aug 5, 2025

12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
12.5K
Activatable fluorescent probes for real-time imaging-guided tumor therapy
Qi-Jia Duan1, Zhong-Yi Zhao1, Yao-Jun Zhang2
1School of Medicine, South China University of Technology, Guangzhou 510006, China.
Advanced Drug Delivery Reviews
|March 24, 2023
Summary
Activatable fluorescent nanoprobes offer advanced tumor imaging for better surgical guidance and drug therapy monitoring. These probes improve cancer treatment accuracy and real-time efficacy assessment.
Area of Science:
- Biomedical Engineering
- Medical Imaging
- Nanotechnology
Background:
- Cancer treatment relies on surgery and drugs, but accurate tumor localization and treatment monitoring remain challenging.
- Conventional imaging techniques have limitations in spatial resolution and real-time feedback for cancer care.
- Fluorescence imaging offers high resolution, real-time capabilities, and cost-effectiveness for tumor diagnosis and treatment evaluation.
Purpose of the Study:
- To review recent advancements in activatable fluorescent probes for cancer diagnosis and therapy.
- To highlight the potential of activatable nanoprobes in fluorescence imaging-guided surgery.
- To discuss the application of activatable nanoprobes in imaging-guided drug therapy.
Main Methods:
- Review of recent literature on fluorescent probes, focusing on site-specifically activatable probes.
- Analysis of small molecule probes and nanoparticle-based probes for tumor imaging.
- Exploration of activatable nanoprobes for surgical guidance and drug therapy monitoring.
Main Results:
- Site-specifically activatable fluorescent probes enable precise tumor delineation.
- Activatable nanoprobes provide real-time feedback on drug therapy efficacy.
- These probes enhance the capabilities of fluorescence imaging in oncology.
Conclusions:
- Activatable fluorescent nanoprobes are crucial for advancing fluorescence imaging in oncology.
- They show significant potential for improving fluorescence imaging-guided surgery and drug therapy.
- Further development of these nanoprobes can revolutionize cancer treatment strategies.

